{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T07:36:31Z","timestamp":1773041791442,"version":"3.50.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>We explored the design and preliminary findings of the Pregnancy and Rheumatoid Arthritis Registry (PRAISE-H), a Japan-wide prospective registry of reproductive-age patients with rheumatoid arthritis (RA) that captures challenges in daily life and complements large database research. PRAISE-H is a nationwide multicentre prospective observational study in which physician assessments and patient-reported outcomes are collected biannually via REDCap over 5 years, with dedicated follow-up during pregnancy and up to 12 months postpartum. As of November 2024, 100 patients (90 women and 10 men) had been registered, and 77 patients (70 women and seven men) were under follow-up. Preliminary analyses showed that 62% of women expressed current or future pregnancy intention. In addition, substantial financial toxicity was observed, particularly among patients receiving biologic disease-modifying antirheumatic drugs (bDMARDs). By emphasizing patients' experiences in everyday environments, PRAISE-H provides insights beyond the scope of conventional database studies. These findings may inform clinical guidelines and health policy initiatives aimed at improving the management of RA in women of childbearing age. Although bDMARDs are increasingly considered viable treatment options during pregnancy, their associated financial consequences warrant further investigation.<\/jats:p>","DOI":"10.3389\/fmed.2026.1773628","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:46:27Z","timestamp":1773038787000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["PRAISE-H study exploring real-world challenges faced by reproductive-age patients with rheumatoid arthritis in Japan"],"prefix":"10.3389","volume":"13","author":[{"given":"Chinatsu","family":"Takai","sequence":"first","affiliation":[{"name":"Japan Drug Information Institute in Pregnancy, Integrated Center for Women's Health, National Center for Child Health and Development","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Fujioka","sequence":"additional","affiliation":[{"name":"Japan Drug Information Institute in Pregnancy, Integrated Center for Women's Health, National Center for Child Health and Development","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikako","family":"Goto","sequence":"additional","affiliation":[{"name":"Japan Drug Information Institute in Pregnancy, Integrated Center for Women's Health, National Center for Child Health and Development","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"102022","DOI":"10.1016\/j.berh.2024.102022","article-title":"Management of pregnant with rheumatoid arthritis: preconception care, pregnancy and lactation strategies, and maternal-fetal outcomes","volume":"39","author":"Nakai","year":"2025","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/acr.21593","article-title":"Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus","volume":"64","author":"Clowse","year":"2012","journal-title":"Arthritis Care Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/art.30327","article-title":"Time to pregnancy among women with rheumatoid arthritis","volume":"63","author":"Jawaheer","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e70296","DOI":"10.1111\/1756-185X.70296","article-title":"Five-year delivery rate and time to delivery among women with and without rheumatoid arthritis: a real-world analysis using a nationwide claims database in Japan","volume":"28","author":"Ohtsu","year":"2025","journal-title":"Int J Rheum Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1136\/annrheumdis-2014-205383","article-title":"Fertility in women with rheumatoid arthritis: influence of disease activity and medication","volume":"74","author":"Brouwer","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"604866","DOI":"10.3389\/fphar.2020.604866","article-title":"IL-6 but not TNF\u03b1 levels are associated with time to pregnancy in female rheumatoid arthritis patients with a wish to conceive","volume":"11","author":"Bongenaar","year":"2020","journal-title":"Front Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s40744-023-00634-1","article-title":"Reproductive effect by rheumatoid arthritis and related autoantibodies","volume":"11","author":"Li","year":"2024","journal-title":"Rheumatol Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1038\/s41598-020-60451-2","article-title":"Peripartum issues in the inflammatory arthritis patient: a survey of the RAPPORT registry","volume":"10","author":"Dissanayake","year":"2020","journal-title":"Sci Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/art.38368","article-title":"Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study","volume":"66","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-219547","article-title":"Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study","volume":"80","author":"Smeele","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ard.2025.02.023","article-title":"EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update","volume":"84","author":"R\u00fcegg","year":"2025","journal-title":"Ann Rheum Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10165-006-0464-8","article-title":"Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice","volume":"16","author":"Yamanaka","year":"2006","journal-title":"Mod Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1093\/rheumatology\/keab894","article-title":"Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark","volume":"61","author":"Hellgren","year":"2022","journal-title":"Rheumatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e002445","DOI":"10.1136\/rmdopen-2022-002445","article-title":"Risk of pre-eclampsia and impact of disease activity and antirheumatic treatment in women with rheumatoid arthritis, axial spondylarthritis and psoriatic arthritis: a collaborative matched cohort study from Sweden and Denmark","volume":"8","author":"Secher","year":"2022","journal-title":"RMD Open."},{"key":"B15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13075-019-2019-3","article-title":"European network of pregnancy registers in rheumatology (EuNeP)-an overview of procedures and data collection","volume":"21","author":"Meissner","year":"2019","journal-title":"Arthritis Res Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/annrheumdis-2020-218356","article-title":"EULAR recommendations for a core data set for pregnancy registries in rheumatology","volume":"80","author":"Meissner","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","article-title":"ACR\/EULAR 2010 rheumatoid arthritis classification criteria","volume":"6","author":"Kay","year":"2012","journal-title":"Rheumatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform."},{"key":"B19","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3899\/jrheum.080182","article-title":"RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories","volume":"35","author":"Pincus","year":"2008","journal-title":"J Rheumatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S0895-4356(98)00095-X","article-title":"Translation, adaptation, and validation of the SF-36 health survey for use in Japan","volume":"51","author":"Fukuhara","year":"1998","journal-title":"J Clin Epidemiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1002\/cncr.28814","article-title":"The development of a financial toxicity patient-reported outcome in cancer: the COST measure","volume":"120","author":"de Souza","year":"2014","journal-title":"Cancer."},{"key":"B23","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive score for financial toxicity (COST)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer."},{"key":"B24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3332\/ecancer.2018.847","article-title":"A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study","volume":"12","author":"Honda","year":"2018","journal-title":"Ecancermedicalscience."},{"key":"B25","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"G\u00f6testam Skorpen","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1080\/14737167.2022.2117690","article-title":"The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States","volume":"22","author":"Ding","year":"2022","journal-title":"Expert Rev Pharmacoecon Outcomes Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"102017","DOI":"10.1016\/j.berh.2024.102017","article-title":"Role of rheumatoid arthritis registries worldwide: what have they taught us?","volume":"39","author":"Studenic","year":"2025","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00296-022-05206-0","article-title":"Management of chronic rheumatic diseases in women 18-45 years of age in Asia Pacific: insights from patient and clinician surveys","volume":"43","author":"Tanaka","year":"2023","journal-title":"Rheumatol Int."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1773628\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:46:27Z","timestamp":1773038787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1773628\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":28,"alternative-id":["10.3389\/fmed.2026.1773628"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1773628","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"article-number":"1773628"}}